The T1h mAb TREATment for PLAQue Psoriasis (TREAT-PLAQ) trial is designed to study the efficacy and safety of T1h mAb in people with chronic psoriasis
National Cancer Institute-supported clinical trials group was founded in 1995 to support innovative trials for AIDS-associated malignancies.